We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+8.61%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$14.8B
AUM Growth
+$1.53B
Cap. Flow
+$575M
Cap. Flow %
3.88%
Top 10 Hldgs %
20.47%
Holding
2,662
New
208
Increased
1,251
Reduced
990
Closed
149

Sector Composition

Rank Sector Weight
1 Technology 9.79%
2 Consumer Discretionary 5%
3 Healthcare 4.52%
4 Financials 4.2%
5 Communication Services 3.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CUB
2626
DELISTED
Cubic Corporation
CUB
-4,787
Closed -$230K
PE
2627
DELISTED
PARSLEY ENERGY INC
PE
-30,805
Closed -$329K
TCO
2628
DELISTED
Taubman Centers Inc.
TCO
-8,047
Closed -$304K
GPOR
2629
DELISTED
Gulfport Energy Corp.
GPOR
-19,790
Closed -$22K
VSLR
2630
DELISTED
VIVINT SOLAR, INC.
VSLR
-15,152
Closed -$150K
DIVY
2631
DELISTED
Reality Shares DIVS ETF
DIVY
-10,650
Closed -$234K
ZN
2632
DELISTED
Zion Oil & Gas, Inc.
ZN
-21,104
Closed -$6K
BFYT
2633
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
-24,377
Closed -$499K
SMRT
2634
DELISTED
Stein Mart Inc
SMRT
-48,350
Closed -$20K
VAL
2635
DELISTED
Valaris plc Class A Ordinary Share
VAL
-11,775
Closed -$8K
JPMV
2636
DELISTED
iShares Edge MSCI Min Vol Japan ETF
JPMV
-4,316
Closed -$262K
DNR
2637
DELISTED
Denbury Resources, Inc.
DNR
-75,793
Closed -$21K
NE
2638
DELISTED
Noble Corporation
NE
-76,042
Closed -$24K
TMUSR
2639
DELISTED
T-Mobile US, Inc. Subscription Rights Expiring 7/27/2020
TMUSR
-10,728
Closed -$2K
BGG
2640
DELISTED
Briggs & Stratton Corp.
BGG
-12,550
Closed -$16K
HCR
2641
DELISTED
Hi-Crush Inc. Common Stock
HCR
-34,829
Closed -$5K
ADRE
2642
DELISTED
Invesco BLDRS Emerging Markets 50 ADR Index Fund
ADRE
-6,665
Closed -$264K
LVHB
2643
DELISTED
Innovator Lunt Low Vol/High Beta Tactical ETF
LVHB
-40,083
Closed -$1.23M
TERP
2644
DELISTED
TerraForm Power, Inc
TERP
-23,106
Closed -$426K
CIZ
2645
DELISTED
VictoryShares Developed Enhanced Volatility Wtd ETF
CIZ
-7,683
Closed -$207K
NLSN
2646
DELISTED
Nielsen Holdings plc
NLSN
-12,112
Closed -$180K
SIVB
2647
DELISTED
SVB Financial Group
SIVB
-1,129
Closed -$243K
WLL
2648
DELISTED
Whiting Petroleum Corporation
WLL
-235
Closed -$20K
IBMI
2649
DELISTED
iShares iBonds Sep 2020 Term Muni Bond ETF
IBMI
-30,694
Closed -$782K
PLM
2650
DELISTED
PolyMet Mining Corp.
PLM
-2,609
Closed -$11K

Similar funds

Cambridge Investment Research Advisors's Q3 2020 Portfolio in Review

As of Q3 2020, Cambridge Investment Research Advisors held 2,662 positions worth $14.8B, up 12% from $13.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Cambridge Investment Research Advisors deployed $575M of net new capital in Q3 2020, opening 208 new positions and adding to 1,251 existing holdings. Its largest new stake was Invesco Building & Construction ETF: 187,041 shares worth $6.78M.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was C.H. Robinson, an estimated $26.2M trimmed.

  • Cambridge Investment Research Advisors's largest Q3 2020 buy was Invesco Building & Construction ETF: 187,041 shares worth $6.78M.
  • Cambridge Investment Research Advisors added most to Bristol-Myers Squibb in Q3 2020, an estimated $56.7M increase.
  • Cambridge Investment Research Advisors's biggest Q3 2020 reduction was C.H. Robinson, cutting an estimated $26.2M.
  • Cambridge Investment Research Advisors fully exited WisdomTree International ESG Fund in Q3 2020, selling an estimated $11.4M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $14.8B portfolio in Q3 2020.
  • Cambridge Investment Research Advisors opened 208 new positions and closed 149 in Q3 2020.
  • Cambridge Investment Research Advisors's portfolio value rose 12% quarter-over-quarter to $14.8B.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2020, filed 29 Oct 2020.